J&J Ottava robotic surgery won FDA de novo authorization for ten general surgery procedures on July 22, 2026, breaking ...
Intuitive Surgical, Boston Scientific and Stryker remain in focus as demand, execution and capital discipline shape the US ...
ISRG's expanding robotic surgery ecosystem and innovation pipeline give it an edge over Abbott for investors seeking stronger long-term MedTech growth.
Qualcomm, Intuitive Surgical and Stryker lead today's top analyst reports, spotlighting growth drivers, strategic initiatives and ongoing challenges.
Intuitive, a leading medical technology company, reported solid performance in its second quarter 2026 earnings conference ...
Wall Street slipped as a deepening chip selloff weighed on sentiment, with the Nasdaq leading losses. Nvidia declined while ...
Intuitive Surgical Inc. ISRG stock fell sharply Friday after the company reaffirmed its 2026 da Vinci procedure growth ...
GhanaVisa.com, a private online visa and travel authorization assistance platform, today announced a significant ...
Chip stocks led a global sell-off, Netflix plunged on weak guidance, and U.S.-Iran tensions weighed on investor sentiment.
Intuitive Surgical (NASDAQ:ISRG) reported a solid second quarter of 2026, with management pointing to continued global ...
Slowing Procedure Growth and Tariffs Take Center Stage Just now Live Intuitive Surgical’s (NASDAQ: ISRG) second-quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results